Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZVRA
#2833
Zevra Therapeutics, Inc. Common Stock
9.690
0
USD
-0.31%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-0.31%
Mudança mensal
-8.04%
Mudança em 6 meses
-8.93%
Mudança anual
-8.93%
Fechamento anterior
9.720
0
Abrir
9.750
0
Bid
Ask
Mínimo
9.690
0
High
9.755
0
Volume
78
Mercados
Ações
Cuidados de saúde
ZVRA
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
28.38 M
34.42 M
34.54 M
43.43 M
54.12 M
58.71 M
—
Valuation ratios
Enterprise value
—
—
—
297.32 M
477.84 M
526.86 M
2.01 B
Price to earnings ratio
—
—
—
-5.26
-3.66
6.64
-14.66
Price to sales ratio
—
—
—
8.82
16.34
4.82
57.18
Price to cash flow ratio
—
—
—
-7.22
-5.54
-321.07
-376.89
Price to book ratio
—
—
—
3.91
9.72
3.32
10.17
Enterprise value to EBITDA ratio
—
—
—
-5.12
-4.81
5.18
25.4
Profitability ratios
Return on assets %
-1.14
-0.06
-0.36
-0.27
-0.59
0.29
0.31
Return on equity %
0.19
-0.07
-0.48
-0.74
-2.66
0.54
0.64
Return on invested capital %
-551.89
272.36
-707.95
-249.94
-352.06
-254.33
-354.14
Gross margin %
100
100
96.72
89.28
42.18
84.52
328.46
Operating margin %
-42.21
26.98
-406.44
-180.63
-368.47
-59.12
-257.57
EBITDA margin %
-40.16
27.87
-42.2
-180.26
-367.86
84
142.24
Net margin %
-96.03
-29.86
-397.24
-167.69
-446.85
78.17
307.03
Liquidity ratios
Quick ratio
—
—
—
1.05
2.47
5.63
24.94
Current ratio
1.11
27.2
7.93
1.18
2.53
5.68
25.17
Inventory turnover
—
—
—
—
2.31
8.89
10.04
Asset turnover
1.22
0.4
0.08
0.19
0.13
0.46
0.46
Solvency ratios
Debt to assets ratio
6.21
0.01
0.12
0.25
0.34
0.22
1.06
Debt to equity ratio
-1.05
0.01
0.16
0.71
1.52
0.41
2.92
Long term debt to total assets ratio
6.04
0
0.11
0.25
0.33
0.22
1.03
Long term debt to total equity ratio
-1.02
0
0.15
0.69
1.5
0.4
2.84
Per share metrics
Operating cash flow per share
—
0.35
-0.54
-0.95
-1.51
-0.03
0.19
EBIT per share
—
0.26
-1.23
-1.4
-1.59
0.28
0.35
EBITDA per share
—
0.27
-0.13
-1.4
-1.88
1.56
0.61
Total debt per share
—
0.05
0.41
1.23
1.3
1.1
2.78
Cash per share
—
3.77
2.4
1.91
1.5
3.34
9.94
Net current asset value per share
—
3.87
2.7
2.45
1.86
3.89
11.21
Tangible book value per share
—
4.27
2.49
-0.34
-0.74
2.51
6.83
Working capital per share
—
3.72
2.36
0.37
1.12
3.21
9.79
Book value per share
—
4.27
2.49
1.74
0.86
2.7
6.8
Notícias
Receitas de royalties da XOMA no 1º tri de 2026 sobem 68% e portfólio supera 120 ativos
BTIG inicia cobertura de Zevra Therapeutics com recomendação de compra
BTIG initiates Zevra Therapeutics stock with buy on Miplyffa outlook
Micron and BioNTech among market cap stock movers on Tuesday
Micron and Palantir among market cap stock movers on Tuesday
ExxonMobil, Chevron edge lower premarket; Hewlett Packard Enterprise climbs
ExxonMobil e Chevron recuam no pré-mercado; Hewlett Packard Enterprise sobe
Guggenheim eleva preço-alvo das ações da Zevra Therapeutics para US$ 23
Guggenheim raises Zevra Therapeutics stock price target to $23
Zevra Therapeutics supera previsões de lucro no 4º tri de 2025
Earnings call transcript: Zevra Therapeutics Q4 2025 earnings beat forecasts
Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call Transcript